|
|
|
|
pmid:
|
Tong H et al. |
Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. |
2005 |
Anal. Biochem. |
pmid:15582558
|
Bergstrom JD et al. |
Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. |
1995 |
Annu. Rev. Microbiol. |
pmid:8561474
|
Kaneshiro ES et al. |
Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817720
|
da Silva MF et al. |
In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26055383
|
Ness GC et al. |
Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. |
1996 |
Arch. Biochem. Biophys. |
pmid:8561503
|
Bansal VS and Vaidya S |
Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes. |
1994 |
Arch. Biochem. Biophys. |
pmid:7986083
|
Vaidya S et al. |
Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A. |
1998 |
Arch. Biochem. Biophys. |
pmid:9647670
|
Peffley DM and Gayen AK |
Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level. |
1997 |
Arch. Biochem. Biophys. |
pmid:9016820
|
Thompson JF et al. |
Truncation of human squalene synthase yields active, crystallizable protein. |
1998 |
Arch. Biochem. Biophys. |
pmid:9473303
|
Soltis DA et al. |
Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems. |
1995 |
Arch. Biochem. Biophys. |
pmid:7864626
|
Ness GC et al. |
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver. |
1994 |
Arch. Biochem. Biophys. |
pmid:8109970
|
Bedi M et al. |
Inhibition of squalene synthase upregulates PCSK9 expression in rat liver. |
2008 |
Arch. Biochem. Biophys. |
pmid:18054775
|
Handschin C et al. |
Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. |
2005 |
Arch. Biochem. Biophys. |
pmid:15629111
|
Lopez D et al. |
Compensatory responses to inhibition of hepatic squalene synthase. |
1998 |
Arch. Biochem. Biophys. |
pmid:9514656
|
Ness GC et al. |
Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase. |
1994 |
Arch. Biochem. Biophys. |
pmid:7911291
|
Keller RK et al. |
Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. |
1996 |
Arch. Biochem. Biophys. |
pmid:8645011
|
Loike JD et al. |
Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15345508
|
Schneiders MS et al. |
Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. |
2006 |
Arthritis Rheum. |
pmid:16802371
|
Pirillo A et al. |
Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070296
|
Ourlin JC et al. |
A Link between cholesterol levels and phenobarbital induction of cytochromes P450. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:11846416
|
Hartmann MA et al. |
Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin. |
2000 |
Biochem. Soc. Trans. |
pmid:11171211
|
Thelin A et al. |
Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. |
1994 |
Biochim. Biophys. Acta |
pmid:7811707
|
Keller RK |
Squalene synthase inhibition alters metabolism of nonsterols in rat liver. |
1996 |
Biochim. Biophys. Acta |
pmid:8908150
|
Bentinger M et al. |
Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis. |
2014 |
Biochim. Biophys. Acta |
pmid:24747199
|
Henneman L et al. |
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS. |
2011 |
Biochim. Biophys. Acta |
pmid:21237288
|
Daicho K et al. |
The ergosterol biosynthesis inhibitor zaragozic acid promotes vacuolar degradation of the tryptophan permease Tat2p in yeast. |
2007 |
Biochim. Biophys. Acta |
pmid:17531951
|
McHale-Owen H and Bate C |
Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers. |
2018 |
Biochim. Biophys. Acta |
pmid:29247837
|
Li HY et al. |
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. |
2003 |
Blood |
pmid:12506040
|
Wilson R et al. |
Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide. |
2007 |
BMC Neurosci |
pmid:18034899
|
Corsini A et al. |
[Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells]. |
1997 |
C. R. Seances Soc. Biol. Fil. |
pmid:9255346
|
Lanterna C et al. |
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice. |
2016 |
Cancer Immunol. Immunother. |
pmid:27520505
|
Cox RJ et al. |
Rapid cloning and expression of a fungal polyketide synthase gene involved in squalestatin biosynthesis. |
2004 |
Chem. Commun. (Camb.) |
pmid:15489970
|
Bonsch B et al. |
Identification of genes encoding squalestatin S1 biosynthesis and in vitro production of new squalestatin analogues. |
2016 |
Chem. Commun. (Camb.) |
pmid:27056201
|
Liddle E et al. |
In vitro kinetic study of the squalestatin tetraketide synthase dehydratase reveals the stereochemical course of a fungal highly reducing polyketide synthase. |
2017 |
Chem. Commun. (Camb.) |
pmid:28106181
|
Wang Y and Metz P |
A general access to zaragozic acids: total synthesis and structure elucidation of zaragozic acid D and formal syntheses of zaragozic acids A and C. |
2011 |
Chemistry |
pmid:21328504
|
Hirata Y et al. |
Total syntheses of zaragozic acids A and C by a carbonyl ylide cycloaddition strategy. |
2006 |
Chemistry |
pmid:17106907
|
Pant A and Kocarek TA |
Role of Phosphatidic Acid Phosphatase Domain Containing 2 in Squalestatin 1-Mediated Activation of the Constitutive Androstane Receptor in Primary Cultured Rat Hepatocytes. |
2016 |
Drug Metab. Dispos. |
pmid:26700959
|
Gardner RG and Hampton RY |
A 'distributed degron' allows regulated entry into the ER degradation pathway. |
1999 |
EMBO J. |
pmid:10545111
|
Flury I et al. |
INSIG: a broadly conserved transmembrane chaperone for sterol-sensing domain proteins. |
2005 |
EMBO J. |
pmid:16270032
|
Weivoda MM and Hohl RJ |
Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation. |
2011 |
Endocrinology |
pmid:21586555
|
Vlahcevic ZR et al. |
Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. |
1997 |
Gastroenterology |
pmid:9394735
|
Paintlia AS et al. |
Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. |
2010 |
Glia |
pmid:20578043
|
Pandak WM et al. |
Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. |
2002 |
Hepatology |
pmid:12029625
|
Kojro E et al. |
Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. |
2010 |
J. Alzheimers Dis. |
pmid:20413873
|
Dawson MJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. |
1992 |
J. Antibiot. |
pmid:1624366
|
Sidebottom PJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation. |
1992 |
J. Antibiot. |
pmid:1624367
|
Jones CA et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis. |
1992 |
J. Antibiot. |
pmid:1429235
|
Middleton RF et al. |
Novel squalestatins produced by biotransformation. |
1995 |
J. Antibiot. |
pmid:7775268
|
Chen TS et al. |
The preparation of zaragozic acid A analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8002393
|
Hasumi K et al. |
Competitive inhibition of squalene synthetase by squalestatin 1. |
1993 |
J. Antibiot. |
pmid:8501015
|
Onishi JC et al. |
Antimicrobial activity of viridiofungins. |
1997 |
J. Antibiot. |
pmid:9186560
|
Cannell RJ et al. |
Production of additional squalestatin analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8150722
|
Baxter A et al. |
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. |
1992 |
J. Biol. Chem. |
pmid:1601846
|
Correll CC and Edwards PA |
Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. |
1994 |
J. Biol. Chem. |
pmid:8276863
|
Gibbs JB et al. |
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. |
1993 |
J. Biol. Chem. |
pmid:8463291
|
Lindsey S and Harwood HJ |
Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation. |
1995 |
J. Biol. Chem. |
pmid:7721822
|
Bostedor RG et al. |
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. |
1997 |
J. Biol. Chem. |
pmid:9083051
|
Ravid T et al. |
The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. |
2000 |
J. Biol. Chem. |
pmid:10964918
|
Bate C et al. |
Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. |
2004 |
J. Biol. Chem. |
pmid:14754889
|
Haeuptle MA et al. |
Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid. |
2011 |
J. Biol. Chem. |
pmid:21183681
|
Vukelic S et al. |
Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. |
2010 |
J. Biol. Chem. |
pmid:19903814
|
Brusselmans K et al. |
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. |
2007 |
J. Biol. Chem. |
pmid:17483544
|
Liu CI et al. |
Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase. |
2012 |
J. Biol. Chem. |
pmid:22474324
|
Kahlon AK et al. |
Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. |
2010 |
J. Biomol. Struct. Dyn. |
pmid:20645653
|
Pastar I et al. |
Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration. |
2016 |
J. Cell. Physiol. |
pmid:26916741
|
Linetti A et al. |
Cholesterol reduction impairs exocytosis of synaptic vesicles. |
2010 |
J. Cell. Sci. |
pmid:20103534
|
Zúñiga-Hertz JP et al. |
Distinct pathways of cholesterol biosynthesis impact on insulin secretion. |
2015 |
J. Endocrinol. |
pmid:25453115
|
Stein W et al. |
Prevention of transplant coronary artery disease by prenylation inhibitors. |
2011 |
J. Heart Lung Transplant. |
pmid:21458297
|
Molina S et al. |
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. |
2007 |
J. Hepatol. |
pmid:17156886
|
Doerner KC et al. |
Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures. |
1995 |
J. Lipid Res. |
pmid:7665995
|
Petras SF et al. |
HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. |
1999 |
J. Lipid Res. |
pmid:9869647
|
Quade-Lyssy P et al. |
Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. |
2013 |
J. Lipid Res. |
pmid:23966666
|
Procopiou PA et al. |
The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues. |
1994 |
J. Med. Chem. |
pmid:7932554
|
Biftu T et al. |
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. |
1994 |
J. Med. Chem. |
pmid:8308869
|
Bamford MJ et al. |
The squalestatins: synthesis and biological activity of some C3-modified analogues; replacement of a carboxylic acid or methyl ester with an isoelectronic heterocyclic functionality. |
1995 |
J. Med. Chem. |
pmid:7658437
|
Procopiou PA et al. |
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. |
1996 |
J. Med. Chem. |
pmid:8691471
|
Ponpipom MM et al. |
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. |
1994 |
J. Med. Chem. |
pmid:7966163
|
Pedretti A et al. |
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. |
2002 |
J. Med. Chem. |
pmid:11906287
|
Chan C et al. |
The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. |
1996 |
J. Med. Chem. |
pmid:8568810
|
Dufresne C et al. |
Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. |
1993 |
J. Nat. Prod. |
pmid:8289063
|
Michikawa M and Yanagisawa K |
Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. |
1999 |
J. Neurochem. |
pmid:10349836
|
Crick DC et al. |
Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1. |
1995 |
J. Neurochem. |
pmid:7643114
|
Fünfschilling U et al. |
Critical time window of neuronal cholesterol synthesis during neurite outgrowth. |
2012 |
J. Neurosci. |
pmid:22649242
|
Naito S et al. |
Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5. |
2002 |
J. Org. Chem. |
pmid:12054955
|
Freeman-Cook KD and Halcomb RL |
A symmetry-based formal synthesis of zaragozic acid A. |
2000 |
J. Org. Chem. |
pmid:10987953
|
Rondini EA et al. |
Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes. |
2015 |
J. Pharmacol. Exp. Ther. |
pmid:26427720
|
Rondini EA et al. |
Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27225895
|
Stankewich MC et al. |
Alterations in cell cholesterol content modulate Ca(2+)-induced tight junction assembly by MDCK cells. |
1996 |
Lipids |
pmid:8869884
|
Michikawa M and Yanagisawa K |
Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. |
1999 |
Mech. Ageing Dev. |
pmid:10360679
|
Cannell RJ et al. |
Follow-up of natural products isolation. |
2012 |
Methods Mol. Biol. |
pmid:22367909
|
Gardner RG et al. |
In vivo action of the HRD ubiquitin ligase complex: mechanisms of endoplasmic reticulum quality control and sterol regulation. |
2001 |
Mol. Cell. Biol. |
pmid:11390656
|
Kocarek TA et al. |
Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. |
1998 |
Mol. Pharmacol. |
pmid:9730906
|
Kocarek TA and Mercer-Haines NA |
Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. |
2002 |
Mol. Pharmacol. |
pmid:12391282
|
Forsman U et al. |
4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. |
2010 |
Nat. Chem. Biol. |
pmid:20526342
|
Lasserre R et al. |
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. |
2008 |
Nat. Chem. Biol. |
pmid:18641634
|
Kelly MJ and Roberts SM |
Synthetic chemistry. Combating cholesterol. |
1995 |
Nature |
pmid:7816124
|
Calter MA and Zhu C |
Scope and diastereoselectivity of the "interrupted" Feist-Bénary reaction. |
2002 |
Org. Lett. |
pmid:11796051
|
Calter MA et al. |
Rapid synthesis of the 7-deoxy zaragozic acid core. |
2002 |
Org. Lett. |
pmid:11796052
|
Liu N et al. |
Identification and Heterologous Production of a Benzoyl-Primed Tricarboxylic Acid Polyketide Intermediate from the Zaragozic Acid A Biosynthetic Pathway. |
2017 |
Org. Lett. |
pmid:28605916
|